Financials
- Market Capitalization 564.66 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2824 | DRUG Bright Minds Biosciences Inc. - common stock | 75.93 USD | -2.45% | +11.88% | +22.76% | +192.49% | 579.79 M USD | ||
| 2835 | IMMX Immix Biopharma, Inc. - Common Stock | 10.52 USD | -5.31% | -0.66% | +22.61% | +262.76% | 572.41 M USD | ||
| 2893 | ARVN Arvinas, Inc. - Common Stock | 8.10 USD | -2.06% | -7.85% | +5.74% | -12.90% | 522.62 M USD | ||
| 2916 | XOMA XOMA Royalty Corporation - Common Stock | 40.17 USD | -9.16% | -8.39% | -3.99% | +13.96% | 503.77 M USD |
Frequently asked questions about Ginkgo Bioworks Holdings, Inc. Class A Common Stock
What is the Ginkgo Bioworks Holdings, Inc. Class A Common Stock stock price today?
The current price of Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) is 9.06. Over the past 24 hours, the stock has changed by -0.66%. Follow the DNA chart for real-time price dynamics.
What is the stock ticker of Ginkgo Bioworks Holdings, Inc. Class A Common Stock?
Ginkgo Bioworks Holdings, Inc. Class A Common Stock trades under the ticker DNA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ginkgo Bioworks Holdings, Inc. Class A Common Stock stock going up?
DNA has changed by -9.94% over the last week, +10.22% over the last month, and +2.03% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Ginkgo Bioworks Holdings, Inc. Class A Common Stock net income for the last quarter?
Ginkgo Bioworks Holdings, Inc. Class A Common Stock reported net income of -82.59 M for the last quarter. The previous quarter showed -80.75 M, which means net income changed by -2.27%.
How many employees does Ginkgo Bioworks Holdings, Inc. Class A Common Stock have?
As of the latest available data, Ginkgo Bioworks Holdings, Inc. Class A Common Stock has 485 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ginkgo Bioworks Holdings, Inc. Class A Common Stock EBITDA?
Ginkgo Bioworks Holdings, Inc. Class A Common Stock EBITDA is -63.58 M, and its EBITDA margin is -275.59%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ginkgo Bioworks Holdings, Inc. Class A Common Stock stock?
You can buy Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ginkgo Bioworks Holdings, Inc. Class A Common Stock stock?
Investing in Ginkgo Bioworks Holdings, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DNA chart and related analysis on metatrader.com as part of your research.